Market Overview

Impax Labs Enters Commercialization Deal with Perrigo

Related PRGO
#PreMarket Primer: Tuesday, July 22: Separatists Hand Over Remains From Malaysian Airlines Flight
Perrigo Down 3% On Sale Rumor
Horizon Inks $660M Reverse Merger With Ireland's Vidara (Fox Business)
Related IPXL
Why Lannett Shares Are Down More Than 16%
Impax Laboratories (IPXL): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape

Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that it will collaborate with Perrigo Company (NASDAQ: PRGO;TASE) on the development, manufacturing and commercialization of an extended topical generic drug product with first to market potential. The product and terms of the agreement were not disclosed.

Posted-In: News

 

Most Popular

Related Articles (IPXL + PRGO)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters